Therefore, the primary aim of our study was to investigate how the expression of growth promoting (cyclin D1, epidermal growth factor receptor [EGFR], Ki-67) and growth suppressing (p21, p27, p53) tumor markers and CD31 in the primary tumor tissue influenced the outcome of patients with unresectable SCCOP. The gene discussed is EGFR; the disease is neoplasm.